Plus   Neg

STADA Arzneimittel Increases FY19 Targets - Quick Facts

STADA Arzneimittel AG (STDAY.PK,STDAF.PK) announced its Executive Board increased the medium-term growth targets for the Group for 2019. The company now expects: adjusted Group sales of 2.65 to 2.70 billion euros (previously: about 2.60 billion euros); adjusted EBITDA in a range between 570 and 590 million euros (previously: about 510 million euros); and adjusted net income to increase to between 250 and 270 million euros (previously: about 250 million euros).

The Group said the increase in the medium-term growth targets for 2019 is a reflection of the interim results from the group wide "STADA Plus" program to improve performance that was introduced in the summer of 2016. Additional value enhancement potentials have also been identified as part of the strategy project that was launched at the beginning of the year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Starbucks wants to be more efficient but it is risking the fragile loyalty of its most devoted customers. The ubiquitous chain plans a major push to get coffee lovers to use its mobile app to place their orders, but regulars prefer to buy their lattes by waiting in the queue. According to reports,... Taco Bell, the Mexican fast-food chain owned by Yum Brands Inc. (YUM), Thursday said it will start selling tortilla chips in grocery and convenience stores starting May. The chips will be available in Fire and Mild sauce packet flavors and also in a Classic flavor. "This launch of our first line... Meredith Corp. said Wednesday that it has decided to explore the sale of its Time, Sports Illustrated, Fortune, and Money brands. In addition, the company will cut 1,000 jobs over the next ten months as part of its plan to realize cost synergies from its acquisition of Time Inc. Further, Meredith has notified about 200 employees that their positions have been eliminated.
comments powered by Disqus
Follow RTT